| n | 39 |
| Age (years) | 65 (57 - 68) |
| Sex |
|
| Male | 33 (85%) |
| Female | 6 (15%) |
| Child-Pugh-Score |
|
| A | 37 (95%) |
| B | 2 (5%) |
| MELD | 7 (7-9) |
| Cirrhosis | 36 (92%) |
| Etiology |
|
| Chronic hepatitis B | 13 (33%) |
| Alcohol | 9 (23%) |
| Chronic hepatitis C | 8 (20.5%) |
| Cryptogenic | 8 (20.5%) |
| NASH | 1 (3%) |
| BCLC-stage |
|
| B | 38 (97%) |
| C | 1 (3%) |
| Therapies prior SIRT |
|
| None | 12 (31%) |
| TACE | 17 (44%) |
| Sorafenib | 10 (25.5%) |
| surgery | 8 (20.5%) |
| RFA | 3 (8%) |
| Baseline laboratory |
|
| Leukocytes (/nl) | 6.1 (4.5 - 7.8) |
| Thrombocytes (/nl) | 149 (102.5 - 187.0) |
| Bilirubin (mg/dl) | 0.8 (0.6 - 1.2) |
| Albumin (g/dl) | 41.5 (36.0 - 42.8) |
| AFP (U/l) | 135.9 (66.9 - 1480.0) |